Company intelligence / Profile preview

OTCPharm

Moscow, Russia
Ownership
Private
Employees
~1000
Development stage
Other
01

Overview

OTCPharm is the leading over-the-counter (OTC) pharmaceutical company in Russia, specializing in the marketing and distribution of a wide range of consumer health products. Established in 2013 as a spin-off from Pharmstandard, the company manages a portfolio of iconic Russian brands such as Arbidol, Amixin, Pentalgin, and Complivit. Its product offerings span several therapeutic areas, including antivirals, analgesics, vitamins, and cough and cold treatments. OTCPharm operates primarily in the Russian and CIS markets, maintaining a dominant position in the retail pharmacy segment. While the company focuses on commercialization and brand management, it utilizes the manufacturing facilities of its former parent, Pharmstandard.

Therapeutic areas
PsychiatryNeurologyInfectious DiseasesMetabolic Disorders
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

8 assets

Complivit

Unknown

7 more assets in the full pipeline.

Request access →
03

Partnerships

Pharmstandard

Beyond the preview

Go deeper on OTCPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTCPharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call